About Champion Oncology
Champion Oncology is a company based in Hackensack (United States) founded in 1985.. The company has 213 employees as of April 30, 2024. Champion Oncology operates in a competitive market with competitors including Biocytogen, GenOway, Applied StemCell, Interius Biotherapeutics and Carcinotech, among others.
- Headquarter Hackensack, United States
- Employees 213 as on 30 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Champions Oncology, Inc.
-
Annual Revenue
$56.94 M13.54as on Apr 30, 2024
-
Net Profit
$4.7 M164.56as on Apr 30, 2024
-
EBITDA
$6.49 M228.51as on Apr 30, 2024
-
Latest Funding Round
$14 M (USD), Post-IPO
Mar 12, 2015
-
Investors
Perceptive Advisors
& 5 more
-
Employee Count
213
as on Apr 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Champion Oncology
Champion Oncology is a publicly listed company on the NASDAQ with ticker symbol CSBR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of Champion Oncology
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $14.0M
-
First Round
First Round
(31 Dec 2009)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2015 | Amount | Post-IPO - Champion Oncology | Valuation |
investors |
|
| Dec, 2014 | Amount | Post-IPO - Champion Oncology | Valuation |
investors |
|
| Feb, 2013 | Amount | Post-IPO - Champion Oncology | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Champion Oncology
Champion Oncology has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Perceptive Advisors, 180 Degree Capital and NEA. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Champion Oncology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Champion Oncology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Champion Oncology Comparisons
Competitors of Champion Oncology
Champion Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, GenOway, Applied StemCell, Interius Biotherapeutics and Carcinotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated solutions for next-generation antibody drug development are provided.
|
|
| domain | founded_year | HQ Location |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| domain | founded_year | HQ Location |
Provider of animal and cell line models as tools for drug discovery and diagnostics
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating multiple diseases
|
|
| domain | founded_year | HQ Location |
Provides 3D tumor models and assays for cancer research and preclinical testing services.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Champion Oncology
Frequently Asked Questions about Champion Oncology
When was Champion Oncology founded?
Champion Oncology was founded in 1985 and raised its 1st funding round 24 years after it was founded.
Where is Champion Oncology located?
Champion Oncology is headquartered in Hackensack, United States. It is registered at Hackensack, New Jersey, United States.
How many employees does Champion Oncology have?
As of Apr 30, 2024, the latest employee count at Champion Oncology is 213.
What is the annual revenue of Champion Oncology?
Annual revenue of Champion Oncology is $56.94M as on Apr 30, 2024.
What does Champion Oncology do?
Champions Oncology works towards development of advanced technology solutions and services for personalised oncology drugs. The Champions TumorGraft (CTG) platform uses the patient-derived xenografts (PDX) i.e. human tumor implanted directly into an immunodeficient mouse to study drug response for predictive clinical outcomes. The experts also help analyze medical records and test results, assist in understanding conventional and experimental options and identify and arrange for testing, analysis and study of the patients cancer tissues Translational Oncology Solutions (TOS) aid in predictive outcomes and study of novel drug combinations.
Who are the top competitors of Champion Oncology?
Champion Oncology's top competitors include Biocytogen, Applied StemCell and GenOway.
Is Champion Oncology publicly traded?
Yes, Champion Oncology is publicly traded on NASDAQ under the ticker symbol CSBR.
Who are Champion Oncology's investors?
Champion Oncology has 6 investors. Key investors include Perceptive Advisors, 180 Degree Capital, NEA, Battelle Ventures, and Battery Ventures.
What is Champion Oncology's ticker symbol?
The ticker symbol of Champion Oncology is CSBR on NASDAQ.